Search

Your search keyword '"Schaeverbeke, T"' showing total 725 results
Start Over Author "Schaeverbeke, T"
725 results on '"Schaeverbeke, T"'

102. Is Helicobacter pylori Eradication useful when prescribing NSAIDs?

Author

Broutet, N., Schaeverbeke, T., Zerbib, F., Perie, F., Scribans, C., Joubert-Collin, M., Lamouliatte, H., and Megraud, F.

Subjects
Helicobacter pylori -- Research, Gastrointestinal diseases -- Research, Health, Research
Abstract

N. Broutet [1] T. Schaeverbeke [2] F. Zerbib [3] F. Perie [4] C. Scribans [1] M. Joubert-Collin [4] H. Lamouliatte [3] F. Megraud [1] [15/04] [*] Is Helicobacter pylori Eradication [...]

Published
2001

103. Impact of Failure to Adhere to Treat-to-Target of Rheumatoid Arthritis in Real World Practice: Data from the International Rheumatoid Arthritis Biomarker Program

Author

Maksymowych, W.P., Ostergaard, M., Elkayam, O., Landewe, R., Homik, J., Thorne, C., Backhaus, M., Shaikh, S., Boire, G., Larche, M., Combe, B., Schaeverbeke, T., Saraux, A., Ferraccioli, G., Dougados, M., Barnabe, C., Govoni, M., Tak, P.P., Schaardenburg, D. van, Heijde, D. van der, Dadashova, R., Hutchings, E., Paschke, J., and FitzGerald, O.

Published
2014

105. Un tiers des patients atteints de polyarthrite rhumatoïde (PR) établie sont correctement vaccinés contre la grippe et le pneumocoque et cette proportion augmente : évaluation longitudinale sur 3 ans des 769 patients de l’étude COMEDRA

Author

Gossec, L., primary, Soubrier, M., additional, Frantz, F., additional, Molto, A., additional, Fayet, F., additional, Bardin, T., additional, Balandraud, N., additional, Cerato, M.H., additional, Chalès, G., additional, Valckenaere, I. Chary, additional, Dernis, E., additional, Ziegler, L. Euller, additional, Flipo, R.M., additional, Gaudin, P., additional, Gilson, M., additional, Mariette, X., additional, Mouterde, G., additional, Pouplin, S., additional, Richette, P., additional, Ruyssen-Witrand, A., additional, Saraux, A., additional, Berenbaum, F., additional, Schaeverbeke, T., additional, Sibilia, J., additional, and Dougados, M., additional

Published
2016
Full Text
View/download PDF

106. Pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde : étude descriptive de 189 patients provenant de la cohorte française TRANSLATE

Author

Juge, P.A., primary, Wemeau-Stervinou, L., additional, Marchand-Adam, S., additional, Debray, M.P., additional, Nunes, H., additional, Gazal, S., additional, Ottaviani, S., additional, Schaeverbeke, T., additional, Saindenberg, N., additional, Valeyre, D., additional, Thabut, G., additional, Boissier, M.C., additional, Dunogeant, L., additional, Allanore, Y., additional, Richez, C., additional, Flipo, R.M., additional, Wallaert, B., additional, Richette, P., additional, Cottin, V., additional, Sibilia, J., additional, Borie, R., additional, Coustet, B., additional, Lioté, H., additional, Soubrier, M., additional, Frazier-Mironer, A., additional, Crestani, B., additional, and Dieudé, P., additional

Published
2016
Full Text
View/download PDF

110. Le dépistage et la prévention des comorbidités dans la polyarthrite rhumatoïde (PR) après un programme d’information par infirmier : suivi à 3 ans de 769 patients atteints de PR établie de l’étude COMEDRA

Author

Gossec, L., primary, Soubrier, M., additional, Frantz, F., additional, Molto, A., additional, Fayet, F., additional, Bardin, T., additional, Berenbaum, F., additional, Cerato, M.H., additional, Chalès, G., additional, Valckenaere, I. Chary, additional, Dernis, E., additional, Ziegler, L. Euller, additional, Flipo, R.M., additional, Gaudin, P., additional, Gilson, M., additional, Guis, S., additional, Mariette, X., additional, Mouterde, G., additional, Pouplin, S., additional, Richette, P., additional, Ruyssen-Witrand, A., additional, Saraux, A., additional, Schaeverbeke, T., additional, Sibilia, J., additional, and Dougados, M., additional

Published
2016
Full Text
View/download PDF

111. Analyse comparative des registres de la SFR AIR, ORA et REGATE : un maintien thérapeutique différent en pratique courante

Author

Gottenberg, J.E., primary, Morel, J., additional, Constantin, A., additional, Bardin, T., additional, Cantagrel, A., additional, Combe, B., additional, Dougados, M., additional, Flipo, R.M., additional, Saraux, A., additional, Schaeverbeke, T., additional, Sibilia, J., additional, Soubrier, M., additional, Vittecoq, O., additional, Perrodeau, E., additional, Ravaud, P., additional, and Mariette, X., additional

Published
2016
Full Text
View/download PDF

112. L’auto-évaluation de la maladie dans la polyarthrite rhumatoïde (PR) par l’auto-DAS28 est-elle acceptable au long cours ? Suivi à 3 ans d’un programme réalisé par des infirmiers (COMEDRA) chez 771 patients atteints de PR établie

Author

Gossec, L., primary, Frantz, F., additional, Soubrier, M., additional, Molto, A., additional, Fayet, F., additional, Bardin, T., additional, Berenbaum, F., additional, Cerato, M.H., additional, Chalès, G., additional, Valckenaere, I. Chary, additional, Dernis, E., additional, Ziegler, L. Euller, additional, Flipo, R.M., additional, Gaudin, P., additional, Gilson, M., additional, Guis, S., additional, Mariette, X., additional, Mouterde, G., additional, Pouplin, S., additional, Richette, P., additional, Ruyssen-Witrand, A., additional, Saraux, A., additional, Schaeverbeke, T., additional, Sibilia, J., additional, and Dougados, M., additional

Published
2016
Full Text
View/download PDF

113. Fond génétique partagé entre la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde et la fibrose pulmonaire idiopathique

Author

Juge, P.A., primary, Borie, R., additional, Kannengiesser, C., additional, Gazal, S., additional, Revy, P., additional, Wemeau-Stervinou, L., additional, Debray, M.P., additional, Ottaviani, S., additional, Marchand-Adam, S., additional, Nathan, N., additional, Thabut, G., additional, Richez, C., additional, Nunes, H., additional, Callebaut, I., additional, Justet, A., additional, Leulliot, N., additional, Bonnefond, A., additional, Salgado, D., additional, Richette, P., additional, Desvignes, J.P., additional, Lioté, H., additional, Froguel, P., additional, Allanore, Y., additional, Sand, O., additional, Dromer, C., additional, Flipo, R.M., additional, Clément, A., additional, Béroud, C., additional, Sibilia, J., additional, Coustet, B., additional, Cottin, V., additional, Boissier, M.C., additional, Wallaert, B., additional, Schaeverbeke, T., additional, Le Moal, F. Dastot, additional, Frazier-Mironer, A., additional, Ménard, C., additional, Soubrier, M., additional, Saindenberg, N., additional, Valeyre, D., additional, Amselem, S., additional, Boileau, C., additional, Crestani, B., additional, and Dieudé, P., additional

Published
2016
Full Text
View/download PDF

114. Efficacité et tolérance de tocilizumab par voie sous-cutanée en monothérapie ou en association aux csDMARDs chez des patients atteints de polyarthrite rhumatoïde : résultats à 24 semaines de l’étude française TOSCA

Author

Fautrel, B., primary, Senbel, E., additional, Vittecoq, O., additional, Rist, S., additional, Combe, B., additional, Schaeverbeke, T., additional, Lioté, F., additional, Flipo, R.M., additional, Kamar, D., additional, Pau, D., additional, Conde Da Silva Fraga, E., additional, Pinta, A., additional, and Gaudin, P., additional

Published
2016
Full Text
View/download PDF

115. Identification de marqueurs associés à la présence d’une pneumopathie interstitielle diffuse chez les patients atteints d’une polyarthrite rhumatoïde

Author

Juge, P.A., primary, Wemeau-Stervinou, L., additional, Marchand-Adam, S., additional, Debray, M.P., additional, Nunes, H., additional, Gazal, S., additional, Ottaviani, S., additional, Schaeverbeke, T., additional, Saindenberg, N., additional, Valeyre, D., additional, Thabut, G., additional, Boissier, M.C., additional, Dunogeant, L., additional, Allanore, Y., additional, Richez, C., additional, Flipo, R.M., additional, Wallaert, B., additional, Richette, P., additional, Cottin, V., additional, Sibilia, J., additional, Borie, R., additional, Coustet, B., additional, Lioté, H., additional, Soubrier, M., additional, Frazier-Mironer, A., additional, Crestani, B., additional, and Dieudé, P., additional

Published
2016
Full Text
View/download PDF

121. La tolérance à long terme du rituximab, de l’abatacept et du tocilizumab est similaire d’après les données des registres AIR, ORA et REGATE de la SFR

Author

Gottenberg, J.E., primary, Morel, J., additional, Constantin, A., additional, Bardin, T., additional, Cantagrel, A., additional, Combe, B., additional, Dougados, M., additional, Flipo, R.M., additional, Saraux, A., additional, Schaeverbeke, T., additional, Sibilia, J., additional, Soubrier, M., additional, Vittecoq, O., additional, Perrodeau, E., additional, Ravaud, P., additional, and Mariette, X., additional

Published
2016
Full Text
View/download PDF

122. Association betweenRANK, RANKLandOPGpolymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts

Author

Ruyssen-Witrand, Adeline, primary, Degboé, Yannick, additional, Cantagrel, A, additional, Nigon, D, additional, Lukas, C, additional, Scaramuzzino, S, additional, Allanore, Y, additional, Vittecoq, O, additional, Schaeverbeke, T, additional, Morel, J, additional, Sibilia, J, additional, Cambon-Thomsen, A, additional, Dieudé, P, additional, and Constantin, A, additional

Published
2016
Full Text
View/download PDF

123. SAT0191 Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution To Human Systemic Sclerosis Fibrosis

Author

Truchetet, M.-E., primary, Demoures, B., additional, Guimaraes, J., additional, Bertrand, A., additional, Laurent, P., additional, Douchet, I., additional, Duffau, P., additional, Lazaro, E., additional, Richez, C., additional, Seneschal, J., additional, Constans, J., additional, Pellegrin, J.-L., additional, Schaeverbeke, T., additional, Blanco, P., additional, and Contin-Bordes, C., additional

Published
2016
Full Text
View/download PDF

124. THU0526 Efficacy and Safety of Febuxostat in 73 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Result from A Retrospective 9 Multicenter Study

Author

Juge, P.-A., primary, Truchetet, M.-E., additional, Pillebout, E., additional, Ottaviani, S., additional, Vigneau, C., additional, Loustau, C., additional, Cornec, D., additional, Pascart, T., additional, Snanoudj, R., additional, Bailly, F., additional, Schaeverbeke, T., additional, Saraux, A., additional, Dieudé, P., additional, Flipo, R.-M., additional, Richette, P., additional, Lioté, F., additional, Bardin, T., additional, Chales, G., additional, and Ea, H.-K., additional

Published
2016
Full Text
View/download PDF

125. THU0067 Is Treat-To-Target Really Working? A Longitudinal Analysis in Biodam

Author

Ramiro, S., primary, Landewé, R., additional, van der Heijde, D., additional, FitzGerald, O., additional, Østergaard, M., additional, Homik, J., additional, Elkayam, O., additional, Thorne, J.C., additional, Larche, M., additional, Ferraccioli, G., additional, Backhaus, M., additional, Boire, G., additional, Combe, B., additional, Schaeverbeke, T., additional, Saraux, A., additional, Dougados, M., additional, Adami, S., additional, Govoni, M., additional, Sinigaglia, L., additional, Cantagrel, A., additional, Allaart, C.F., additional, Barnabe, C., additional, Bingham, C.O., additional, Tak, P.P., additional, van Schaardenburg, D., additional, Hammer, H.B., additional, Dadashova, R., additional, Hutchings, E., additional, Paschke, J., additional, and Maksymowych, W.P., additional

Published
2016
Full Text
View/download PDF

128. THU0106 Identification of Markers Associated with The Occurrence of Interstitial Lung Disease in Rheumatoid Arthritis Patients

Author

Juge, P.-A., primary, Wemeau, L., additional, Marchand-Adam, S., additional, Debray, M.-P., additional, Nunes, H., additional, Gazal, S., additional, Ottaviani, S., additional, Schaeverbeke, T., additional, Saindenberg, N., additional, Valeyre, D., additional, Thabut, G., additional, Boissier, M.-C., additional, Dunogeant, L., additional, Allanore, Y., additional, Richez, C., additional, Flipo, R.-M., additional, Wallaert, B., additional, Richette, P., additional, Cottin, V., additional, Sibilia, J., additional, Borie, R., additional, Coustet, B., additional, Liote, H., additional, Soubrier, M., additional, Frazier, A., additional, Crestani, B., additional, and Dieude, P., additional

Published
2016
Full Text
View/download PDF

133. Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry

Author

Salmon, J H, primary, Gottenberg, J E, additional, Ravaud, P, additional, Cantagrel, A, additional, Combe, B, additional, Flipo, R M, additional, Schaeverbeke, T, additional, Houvenagel, E, additional, Gaudin, P, additional, Loeuille, D, additional, Rist, S, additional, Dougados, M, additional, Sibilia, J, additional, Le Loët, X, additional, Meyer, O, additional, Solau-Gervais, E, additional, Marcelli, C, additional, Bardin, T, additional, Pane, I, additional, Baron, G, additional, Perrodeau, E, additional, and Mariette, X, additional

Published
2015
Full Text
View/download PDF

134. AB0444 Impact of Gender on the Response and the Tolerance to Treatment with Abatacept in RA Patients: Results from the “Orencia and Rheumatoid Arthritis” Registry

Author

Nourisson, C., primary, Gottenberg, J.-E., additional, Mariette, X., additional, Mulliez, A., additional, Bardin, T., additional, Cantagrel, A., additional, Combe, B., additional, Dougados, M., additional, Flipo, R.-M., additional, Gaudin, P., additional, Vittecoq, O., additional, Schaeverbeke, T., additional, Sibilia, J., additional, Soubrier, M., additional, Ravaud, P., additional, and Tournadre, A., additional

Published
2015
Full Text
View/download PDF

136. FRI0154 Incidence of Cancers in Patients with Rheumatoid Arthritis and a History of Cancer Treated with Rituximab or Abatacept

Author

Gottenberg, J.E., primary, Morel, J., additional, Ravaud, P., additional, Bardin, T., additional, Cacoub, P., additional, Cantagrel, A., additional, Combe, B., additional, Constantin, A., additional, Dougados, M., additional, Flipo, R.M., additional, Godeau, B., additional, Hachulla, E., additional, Le Loet, X., additional, Schaeverbeke, T., additional, Sibilia, J., additional, Pane, I., additional, Baron, G., additional, and Mariette, X., additional

Published
2015
Full Text
View/download PDF

137. OP0035 Tolerance of Rituximab, Abatacept and Tocilizumab in Common Practice: Analysis of the 3 Registries of the French Society of Rheumatology (Air, Ora and Regate)

Author

Gottenberg, J.-E., primary, Morel, J., additional, Ravaud, P., additional, Bardin, T., additional, Cacoub, P., additional, Cantagrel, A., additional, Combe, B., additional, Constantin, A., additional, Dougados, M., additional, Flipo, R.M., additional, Godeau, B., additional, Hachulla, E., additional, Le Loet, X., additional, Schaeverbeke, T., additional, Sibilia, J., additional, Pane, I., additional, Baron, G., additional, and Mariette, X., additional

Published
2015
Full Text
View/download PDF

139. Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

Author

Rubbert Roth, Andrea, Tak, Paul P, Zerbini, Cristiano, Tremblay, Jean Luc, Carreño, Luis, Armstrong, Gillian, Collinson, Neil, Shaw, Tim M, MIRROR Trial Investigators, Nash, P, Bagga, H, Hall, S, Littlejohn, G, Manolios, N, Van Den Bosch, F, Ximenes, Ac, Mccarthy, T, Atkins, C, Thorne, Jc, Offer, R, Pope, J, Keystone, E, Huang, F, Wu, D, Karjalainen, A, Schaeverbeke, T, Euller Ziegler, L, Jorgensen, C, Nguyen, M, Puechal, X, Wassenberg, S, Heilig, B, Mueller Ladner, U, Wollenhaupt, J, Braun, J, Gauler, G, Szekanecz, Z, Nagy, K, Galeazzi, M, Trotta, F, Bombardieri, S, Salvarani, Carlo, Pellerito, R, Seriolo, B, Adami, S, Bianchi, G, Giacomelli, R, Arioli, G, Cantini, F, Ching, D, Gilchrist, N, Singh, J, Lukac, J, Rovensky, J, Macejova, Z, Kalla, A, Tikly, M, Ally, Mm, Marenco, Jl, Tinture, T, Juanola, J, Alvaro Gracia JM, Rodriguez Heredia JM, Sandoval, Tp, Cheng, Tt, Luo, Sf, Lan, Jl, Osiri, M, Nilganuwong, S, Asavatanabodee, P, Nanagara, R, Louthrenoo, W, Hazleman, Bl, Jubb, R, George, E, Hakim, A, Grennan, D, Gardiner, P, Taylor, J, Mcnally, J, Hutchinson, D, Plant, M., AII - Amsterdam institute for Infection and Immunity, and Clinical Immunology and Rheumatology

Subjects
Male, Gastroenterology, law.invention, Arthritis, Rheumatoid, Antibodies, Monoclonal, Murine-Derived, Adult, Aged, Antirheumatic Agents, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Middle Aged, Treatment Outcome, Randomized controlled trial, law, Rheumatoid, Monoclonal, Clinical endpoint, Medicine, Pharmacology (medical), B-cell depletion, Clinical Science, Repeat treatment, Rheumatoid arthritis, Rituximab, Drug, medicine.drug, Murine-Derived, medicine.medical_specialty, Antibodies, Dose-Response Relationship, Phase III, Rheumatology, Internal medicine, In patient, Dosing, business.industry, Arthritis, medicine.disease, Surgery, Clinical trial, business, Rheumatism
Abstract

Objective. To evaluate the efficacy and safety of three dosing and repeat treatment regimens of rituximab (RTX) plus MTX in patients with active RA. Methods. Patients with active RA despite stable MTX (10–25 mg/week) were randomly assigned to one of the three treatment regimens comprising two courses of RTX given 24 weeks apart: 2 × 500 and 2 × 500 mg; 2 × 500 and 2 × 1000 mg (dose escalation); and 2 × 1000 and 2 × 1000 mg. The primary endpoint was proportion of patients achieving ACR20 at Week 48. Results. At Week 48, ACR20 responses were not statistically significantly different between the dose regimens. Compared with RTX 2 × 500 mg (n = 134) or dose escalation (n = 119), ACR and European League Against Rheumatism (EULAR) outcomes in the RTX 2 × 1000 mg group (n = 93) were consistently higher, with significantly more patients achieving EULAR responses (P = 0.0495). At Week 48, rituximab 2 × 1000 mg was associated with a higher proportion of patients who, following retreatment, maintained or improved their Week 24 responses. Dose escalation from 2 × 500 to 2 × 1000 mg did not appear to be associated with improved outcomes compared with continual 2 × 500 mg. All RTX regimens demonstrated comparable safety. Conclusions. RTX 2 × 500 and 2 × 1000 mg could not be clearly differentiated, although some efficacy outcomes suggest improved outcomes in the rituximab 2 × 1000 mg group. Retreatment from Week 24 resulted in a sustained suppression of disease activity through to Week 48. Trial registration. ClinicalTrials.gov, http://clinicaltrials.gov/, NCT00422383.

Published
2010

142. FRI0323 Prospective Follow-Up of Tocilizumab Treatment in 1503 Patients with Refractory Rheumatoid Arthritis: Tolerance Data at 1 Year from the French Registry Regate (Registry – Roactemra)

Author

Morel, J., primary, Duzanski, M.O., additional, Flipo, R.M., additional, Cantagrel, A., additional, Combe, B., additional, Dougados, M., additional, Mariette, X., additional, Gottenberg, J.E., additional, Soubrier, M., additional, Vittecoq, O., additional, Saraux, A., additional, Schaeverbeke, T., additional, Bardin, T., additional, Rist, S., additional, Ravaud, P., additional, and Sibilia, J., additional

Published
2014
Full Text
View/download PDF

143. THU0485 The SPP1 Rs9138 Variant Contributes to the Severity of Radiologic Damage in Acpa-Negative Rheumatoid Arthritis: Results from the ESPOIR and Leiden EAC Cohorts

Author

Juge, P.-A., primary, Van Steenbergen, H.W., additional, Constantin, A., additional, Tobon, G., additional, Schaeverbeke, T., additional, Combe, B., additional, Devauchelle-Pensec, V., additional, Nigon, D., additional, van der Helm-van Mil, A.H., additional, and Dieudé, P., additional

Published
2014
Full Text
View/download PDF

149. THU0264 In Early Rheumatoid Arthritis (Espoir Cohort), Serum CCL19 Level is Associated with Disease Activity, Autoantibody Secretion and 3-Year Radiographic Progression: Data from the Espoir Cohort

Author

Gottenberg, J.E., primary, Seror, R., additional, Baillet, A., additional, Rincheval, N., additional, Alsaleh, G., additional, Pichot, A., additional, Schaeverbeke, T., additional, Cantagrel, A., additional, Combe, B., additional, and Mariette, X., additional

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results